Blog
RSS FeedPosted by Michael Wonder on 10 Jul 2018
Time to entry for new cancer medicines: from European Union wide marketing authorisation to patient access in Belgium, Estonia, Scotland, and Sweden
10 July 2018 - This study quantified the median time from European Union wide approval to first use for a ...
Posted by Michael Wonder on 09 Jul 2018
SMC rejects ocrelizumab (Ocrevus) for relapsing remitting MS in Scotland
9 July 2018 - The MS Trust is very disappointed that the Scottish Medicines Consortium is unable to recommend ocrelizumab as ...
Posted by Michael Wonder on 09 Jul 2018
SMC - July 2018 decisions
9 July 2018 - The SMC, which advises NHSScotland on newly licensed medicines, has today published advice accepting three new medicines. ...
Posted by Michael Wonder on 13 Jun 2018
Drug approved for leukaemia treatment
11 June 2018 - A drug that reduces the chances of relapse for people with an aggressive type of leukaemia ...
Posted by Michael Wonder on 12 Jun 2018
SMC approves funding for six new therapies on the NHS
12 June 2018 - The Scottish Medicines Consortium has approved NHS funding for six new therapies, offering patients new options ...
Posted by Michael Wonder on 12 Jun 2018
Cystic fibrosis patient backs campaign to make medicines available on NHS
10 June 2018 - A cystic fibrosis patient is calling for a medicine to be made available on the NHS ...
Posted by Michael Wonder on 11 Jun 2018
SMC - June 2018 decisions
11 June 2018 - The SMC, has today published advice accepting six new medicines for use by NHSScotland. ...
Posted by Michael Wonder on 14 May 2018
The Scottish Medicines Consortium accepts use of Kyntheum (brodalumab) for eligible patients with moderate-to-severe plaque psoriasis
11 May 2018 - The SMC has issued advice accepting brodalumab 210 mg for restricted use within NHS Scotland. ...
Posted by Michael Wonder on 14 May 2018
Seven drugs available in England but not Scotland, Holyrood hears
11 May 2018 - Seven drugs to treat patients with a range of conditions from cancer to muscular dystrophy are ...
Posted by Michael Wonder on 10 May 2018
Call for Scottish breast cancer drug deal
10 May 2018 - Ruth Davidson has called for a deal to allow a breast cancer drug that is offered ...
Posted by Michael Wonder on 07 May 2018
SMC - May 2018 decisions
7 May 2018 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has today ...
Posted by Michael Wonder on 30 Apr 2018
Brexit diagnosis predicts drug delay for UK patients
28 April 2018 - One of Scotland’s leading neurologists has warned that Brexit will delay the newest life-saving drugs reaching ...
Posted by Michael Wonder on 09 Apr 2018
Five new medicines accepted by SMC for use by NHSScotland
9 April 2018 - The SMC, has today published advice accepting five new medicines for use by NHSScotland. ...
Posted by Michael Wonder on 03 Apr 2018
Families seek access to 'life-changing' drug
3 April 2018 - Patients with the most severe form of a genetic condition could lose the ability to move, ...
Posted by Michael Wonder on 25 Mar 2018
Fresh hopes that breast cancer drug Perjeta will be made available in Scotland
22 March 2018 - Breast cancer campaigners have welcomed talks aimed at making a life-extending drug available to women in ...